TextAE configuration unavailable!

PubMed:12373350 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-PubTator-for-Tuning

Id	Subject	Object	Predicate	Lexical cue	tao:has_database_id
3	0-13	ChemicalEntity	denotes	Anthracycline	MESH:D018943
4	22-30	DiseaseOrPhenotypicFeature	denotes	toxicity	MESH:D064420
5	106-134	DiseaseOrPhenotypicFeature	denotes	acute promyelocytic leukemia	MESH:D015473
20	163-191	DiseaseOrPhenotypicFeature	denotes	acute promyelocytic leukemia	MESH:D015473
21	193-196	DiseaseOrPhenotypicFeature	denotes	APL	MESH:D015473
22	249-273	DiseaseOrPhenotypicFeature	denotes	congestive heart failure	MESH:D006333
23	275-278	DiseaseOrPhenotypicFeature	denotes	CHF	MESH:D006333
24	325-333	OrganismTaxon	denotes	patients	Tax:9606
25	355-369	DiseaseOrPhenotypicFeature	denotes	cardiotoxicity	MESH:D066126
26	371-386	DiseaseOrPhenotypicFeature	denotes	Cardiac failure	MESH:D006333
27	504-517	ChemicalEntity	denotes	anthracycline	MESH:D018943
28	538-551	ChemicalEntity	denotes	anthracycline	MESH:D018943
29	573-585	ChemicalEntity	denotes	daunorubicin	MESH:D003630
30	599-611	ChemicalEntity	denotes	mitoxantrone	MESH:D008942
31	634-646	ChemicalEntity	denotes	daunorubicin	MESH:D003630
32	672-684	ChemicalEntity	denotes	daunorubicin	MESH:D003630
33	742-757	DiseaseOrPhenotypicFeature	denotes	cardiac failure	MESH:D006333

LitCoin-Disease-Tuning-1

Id	Subject	Object	Predicate	Lexical cue	ID:
T1	22-30	DiseaseOrPhenotypicFeature	denotes	toxicity	DISEASE
T2	78-85	DiseaseOrPhenotypicFeature	denotes	disease	D004194
T3	106-134	DiseaseOrPhenotypicFeature	denotes	acute promyelocytic leukemia	D015473
T4	163-191	DiseaseOrPhenotypicFeature	denotes	acute promyelocytic leukemia	D015473
T5	193-196	DiseaseOrPhenotypicFeature	denotes	APL	D015473
T6	213-220	DiseaseOrPhenotypicFeature	denotes	disease	D004194
T7	249-273	DiseaseOrPhenotypicFeature	denotes	congestive heart failure	D006333
T8	275-278	DiseaseOrPhenotypicFeature	denotes	CHF	D006333
T9	355-369	DiseaseOrPhenotypicFeature	denotes	cardiotoxicity	D066126
T10	371-386	DiseaseOrPhenotypicFeature	denotes	Cardiac failure	D006333
T11	742-757	DiseaseOrPhenotypicFeature	denotes	cardiac failure	D006333

LitEisuke

Id	Subject	Object	Predicate	Lexical cue	#label
T1	22-30	DiseaseOrPhenotypicFeature	denotes	toxicity	DISEASE
T2	106-134	DiseaseOrPhenotypicFeature	denotes	acute promyelocytic leukemia	D015473
T3	163-191	DiseaseOrPhenotypicFeature	denotes	acute promyelocytic leukemia	D015473
T4	193-196	DiseaseOrPhenotypicFeature	denotes	APL	D015473
T5	249-273	DiseaseOrPhenotypicFeature	denotes	congestive heart failure	D006333
T6	275-278	DiseaseOrPhenotypicFeature	denotes	CHF	D006333
T7	355-369	DiseaseOrPhenotypicFeature	denotes	cardiotoxicity	D066126
T8	371-386	DiseaseOrPhenotypicFeature	denotes	Cardiac failure	D006333
T9	742-757	DiseaseOrPhenotypicFeature	denotes	cardiac failure	D006333

sentences

Id	Subject	Object	Predicate	Lexical cue
TextSentencer_T1	0-135	Sentence	denotes	Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia.
TextSentencer_T2	136-314	Sentence	denotes	We describe three cases of acute promyelocytic leukemia (APL) with long-term disease-free survival who developed congestive heart failure (CHF) requiring cardiac transplantation.
TextSentencer_T3	315-370	Sentence	denotes	All three patients presented late-onset cardiotoxicity.
TextSentencer_T4	371-526	Sentence	denotes	Cardiac failure occurred progressively after 31-month, 32-month, and 14-month intervals, respectively, following completion of first anthracycline therapy.
TextSentencer_T5	527-695	Sentence	denotes	Cumulative anthracycline doses were 585 mg of daunorubicin and 64 mg of mitoxantrone in case 1, 1779 mg of daunorubicin in case 2, and 825 mg of daunorubicin in case 3.
TextSentencer_T6	696-772	Sentence	denotes	The questions relating to the pathogenesis of cardiac failure are discussed.
TextSentencer_T7	773-864	Sentence	denotes	We also discuss the prophylactic measures required for such treatment-related side effects.
T1	0-135	Sentence	denotes	Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia.
T2	136-314	Sentence	denotes	We describe three cases of acute promyelocytic leukemia (APL) with long-term disease-free survival who developed congestive heart failure (CHF) requiring cardiac transplantation.
T3	315-370	Sentence	denotes	All three patients presented late-onset cardiotoxicity.
T4	371-526	Sentence	denotes	Cardiac failure occurred progressively after 31-month, 32-month, and 14-month intervals, respectively, following completion of first anthracycline therapy.
T5	527-695	Sentence	denotes	Cumulative anthracycline doses were 585 mg of daunorubicin and 64 mg of mitoxantrone in case 1, 1779 mg of daunorubicin in case 2, and 825 mg of daunorubicin in case 3.
T6	696-772	Sentence	denotes	The questions relating to the pathogenesis of cardiac failure are discussed.
T7	773-864	Sentence	denotes	We also discuss the prophylactic measures required for such treatment-related side effects.

PubmedHPO

Id	Subject	Object	Predicate	Lexical cue
T1	163-191	HP_0004836	denotes	acute promyelocytic leukemia
T2	183-191	HP_0001909	denotes	leukemia
T3	249-273	HP_0001635	denotes	congestive heart failure
T4	260-273	HP_0001635	denotes	heart failure
T5	371-386	HP_0001635	denotes	Cardiac failure
T6	742-757	HP_0001635	denotes	cardiac failure

PubCasesHPO

Id	Subject	Object	Predicate	Lexical cue
AB1	163-191	HP:0004836	denotes	acute promyelocytic leukemia
TI1	106-134	HP:0004836	denotes	acute promyelocytic leukemia
AB2	249-273	HP:0001635	denotes	congestive heart failure

UBERON-AE

Id	Subject	Object	Predicate	Lexical cue
PD-UBERON-AE-B_T1	260-265	http://purl.obolibrary.org/obo/UBERON_0000948	denotes	heart

PubCasesORDO

Id	Subject	Object	Predicate	Lexical cue
AB1	163-191	ORDO:520	denotes	acute promyelocytic leukemia
TI1	106-134	ORDO:520	denotes	acute promyelocytic leukemia

performance-test

Id	Subject	Object	Predicate	Lexical cue
PD-UBERON-AE-B_T1	260-265	http://purl.obolibrary.org/obo/UBERON_0000948	denotes	heart